ATXN3 and Spinocerebellar ataxia type 3: In this study, using our transgenic C. elegans ATXN3 models, we explored whether small molecules that regulate ER stress response activity were able to rescue locomotor phenotypes, neuronal loss and the increased oxidative and ER stress observed in mutant transgenic animals as an early effort for MJD therapy development.